PSUSA/00010525/202404
PSUSA/00010525/202404
PSUSA/00010525/202404
PSUSA/00002001/202404
Human medicines European public assessment report (EPAR): Gavreto, pralsetinib, Date of authorisation: 18/11/2021, Revision: 8, Status: Withdrawn
Opening procedures at EMA to non-EU authorities (OPEN) framework
Two new vaccines against bluetongue recommended for approval
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 14-15 January 2025
Human medicines European public assessment report (EPAR): Pravafenix, fenofibrate,pravastatin, Date of authorisation: 14/04/2011, Revision: 11, Status: Authorised
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13-16 January 2025
PSUSA/00002843/202404
Policy 83: Policy on visiting and collaborating experts involved in the activities of the European Medicines Agency